Heska Corp (HSKA):企業の財務・戦略的SWOT分析

◆英語タイトル:Heska Corp (HSKA) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1342
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Heska Corp (HSKA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Heska Corp (Heska) is an animal health care company, which develops, manufactures and commercializes veterinary diagnostic and specialty products for canine and feline companion animal health. Heska’s product portfolio includes a wide range of blood testing instruments and supplies, software and services, data services, digital imaging products, single use products such as in-clinic diagnostic tests, heartworm preventive products and allergy immunotherapy products. It also provides vaccine and other pharmaceuticals for cattle including porcine, avian, equine, feline and canine. Heska markets its products through telephone sales force, an outside field organization and independent third-party distributors. It has a direct presence in the US, Canada, Switzerland, Australia, France and Spain. Heska is headquartered in Loveland, Colorado, the US.

Heska Corp Key Recent Developments

Jan 24,2020: HESKA: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
May 07,2019: Heska reports first quarter 2019 results
May 06,2019: Heska names Chief Financial Officer to enhance executive team

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Heska Corp – Key Facts
Heska Corp – Key Employees
Heska Corp – Key Employee Biographies
Heska Corp – Major Products and Services
Heska Corp – History
Heska Corp – Company Statement
Heska Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Heska Corp – Business Description
Business Segment: Core Companion Animal Health (CCA)
Overview
Performance
Business Segment: Other Vaccines, Pharmaceuticals and Products (OVP)
Overview
Performance
Geographical Segment: Canada
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other International
Performance
Geographical Segment: The US
Performance
Heska Corp – SWOT Analysis
SWOT Analysis – Overview
Heska Corp – Strengths
Heska Corp – Weaknesses
Heska Corp – Opportunities
Heska Corp – Threats
Heska Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Heska Corp, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jan 24, 2020: HESKA: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
May 07, 2019: Heska reports first quarter 2019 results
May 06, 2019: Heska names Chief Financial Officer to enhance executive team
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Heska Corp, Key Facts
Heska Corp, Key Employees
Heska Corp, Key Employee Biographies
Heska Corp, Major Products and Services
Heska Corp, History
Heska Corp, Other Locations
Heska Corp, Subsidiaries
Heska Corp, Key Competitors
Heska Corp, Ratios based on current share price
Heska Corp, Annual Ratios
Heska Corp, Annual Ratios (Cont...1)
Heska Corp, Annual Ratios (Cont...2)
Heska Corp, Interim Ratios
Heska Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Heska Corp, Performance Chart (2015 - 2019)
Heska Corp, Ratio Charts

★海外企業調査レポート[Heska Corp (HSKA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Datang International Power Generation Co Ltd:発電所・企業SWOT分析
    Datang International Power Generation Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • NanoSmart Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary NanoSmart Pharmaceuticals Inc (NanoSmart) focuses on the development of novel methods for the treatment of cancer and other diseases. The company is evaluating a human-derived anti-nuclear antibody which targets areas of necrosis presence in various different types of cancer tumors. Its prop …
  • JSC Insurance Company Aldagi:企業の戦略・SWOT・財務情報
    JSC Insurance Company Aldagi - Strategy, SWOT and Corporate Finance Report Summary JSC Insurance Company Aldagi - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Central Alabama Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Central Alabama Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Elavon Inc:企業の戦略・SWOT・財務分析
    Elavon Inc - Strategy, SWOT and Corporate Finance Report Summary Elavon Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Sol-Gel Technologies Ltd (SLGL):製薬・医療:M&Aディール及び事業提携情報
    Summary Sol-Gel Technologies Ltd (Sol-Gel) is a clinical-stage dermatology company that identifies, develops and commercializes branded and generic topical dermatological drug products for the treatment of skin diseases. The company’s pipeline products include vered, twin and sirs-t drug candidates. …
  • Noor Takaful:企業の戦略・SWOT・財務分析
    Noor Takaful - Strategy, SWOT and Corporate Finance Report Summary Noor Takaful - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • K.P.R. Mill Ltd:企業の戦略・SWOT・財務情報
    K.P.R. Mill Ltd - Strategy, SWOT and Corporate Finance Report Summary K.P.R. Mill Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • ABX Advanced Biochemical Compounds GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary ABX Advanced Biochemical Compounds GmbH (ABX), a subsidiary of Otsuka Holdings Co Ltd is a provider of biochemical compounds that manufactures, develops, and distributes biochemicals for nuclear medicine. The company provides products such as PET and SPECT precursors and reference standards, …
  • Banca Transilvania S.A.:企業の戦略・SWOT・財務情報
    Banca Transilvania S.A. - Strategy, SWOT and Corporate Finance Report Summary Banca Transilvania S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Lanco Infratech Ltd (LITL):電力:M&Aディール及び事業提携情報
    Summary Lanco Infratech Ltd. (Lanco) is an integrated infrastructure enterprise that operates in diversified fields such as engineering, procurement and construction (EPC); operation and maintenance; and development. Through delivery partners in construction, civil, and electrical engineering, it of …
  • OriGene Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary OriGene Technologies Inc (OriGene) is a research tool company that develops cDNA. The company creates commercial collection of full-length human cDNAs in expression vector. It develops, manufactures and sells genome research and diagnostic products. OriGene’s products include qPCR reagents, …
  • Hangzhou Tigermed Consulting Co Ltd (300347):企業の財務・戦略的SWOT分析
    Summary Hangzhou Tigermed Consulting Co Ltd (Tigermed) is a contract research organization (CRO) that provides clinical trial services. It offers regulatory submission and approval, medical translation and GMP (Good Manufacturing Practice) consulting, medical monitoring, project management, medical …
  • Plexus Corp (PLXS):企業の財務・戦略的SWOT分析
    Plexus Corp (PLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Minor International PCL:企業の戦略・SWOT・財務情報
    Minor International PCL - Strategy, SWOT and Corporate Finance Report Summary Minor International PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Anteo Diagnostics Ltd (ADO):企業の製品パイプライン分析2018
    Summary Anteo Diagnostics Ltd (Anteo Diagnostics) is a leading medical technology company that develops and commercializes healthcare products. The company along with its subsidiaries provides immunoassays, in-vitro diagnostics, and point of care (PoC) tests to life sciences, bio-separation, clinica …
  • The Housing Bank for Trade and Finance:企業の戦略・SWOT・財務分析
    The Housing Bank for Trade and Finance - Strategy, SWOT and Corporate Finance Report Summary The Housing Bank for Trade and Finance - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Rand Worldwide Inc (RWWI):企業の財務・戦略的SWOT分析
    Summary Rand Worldwide Inc (Rand Worldwide) is a technology company that offers engineering design and information technology solutions. The company operates through divisions such as IMAGINiT technologies, ASCENT-center for technical knowledge, and Rand 3D. It provides 3D design engineering softwar …
  • Kineta Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kineta Inc (Kineta) is a biotech company that develops novel immuno-therapies. The company offers small-molecule compounds that target RIG-I-like receptor pathways and intracellular IRF3-inducing pathways for applications in cancer. Its KCP-400 is a novel non-opioid therapy for the treatment …
  • Sucrerie Couplet SA:企業の戦略・SWOT・財務分析
    Sucrerie Couplet SA - Strategy, SWOT and Corporate Finance Report Summary Sucrerie Couplet SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆